Skip to main content

‘arthritis drug’

Research Snapshot: BME team demonstrates potential for 1st clinically successful osteoarthritis drug

Sep. 2, 2021—THE IDEA Post-traumatic osteoarthritis—caused by degraded cartilage that cushions the ends of bones in joints—occurs after a joint injury. With the knowledge that PTOA will lead to earlier onset and faster progression of osteoarthritis following an injury, researchers including Craig Duvall, Cornelius Vanderbilt Professor of Engineering, set out to develop a drug for the prevention of...

Read more

Arthritis drug could be first to stop heart valve calcification

Jun. 13, 2017—The first drug to treat calcification of heart valves may be one originally designed for rheumatoid arthritis. Today in Circulation, the journal of the American Heart Association, Vanderbilt University researchers published findings that the drug – a monoclonal antibody known as SYN0012 – shows promise in keeping heart valve leaflets supple. About a quarter of...

Read more